Le Lézard
Classified in: Health, Science and technology
Subject: PSF

ATLANTIC GENERAL HOSPITAL PROVIDES NOTICE OF DATA PRIVACY EVENT


BERLIN, Md., March 24, 2023 /PRNewswire/ -- Atlantic General Hospital ("AGH") is providing notice of an incident that may affect the privacy of information. AGH takes this incident seriously. The following provides details of the incident, AGH's response, and steps individuals may take to better protect against possible misuse of their personal information, should they feel it appropriate to do so.

What Happened? On January 29, 2023, AGH discovered encrypted files on certain computer systems. AGH immediately launched an investigation, with the assistance of third-party forensic specialists, to determine the nature and scope of the activity. The investigation determined that there was unauthorized access to certain of its servers beginning on January 20, 2023. Through the investigation, AGH learned that certain files within its network were subject to unauthorized access during the period of unauthorized access. AGH then undertook a comprehensive review of these files to determine what data was contained within the files and to whom that data relates. On March 6, 2023, AGH determined that the impacted files contained certain information related to patients and/or employees. On March 24, 2023, AGH began mailing letters to potentially impacted individuals. AGH has seen no evidence of misuse of any information related to this incident.

What Information Was Involved? While the specific data elements vary for each potentially affected individual, the scope of information potentially involved includes an individual's name and one or more of Social Security number, driver's license number, financial account information, date of birth, medical record number, treating/referring physician, health insurance information, subscriber number, medical history information, diagnosis/treatment information.

AGH takes the confidentiality, privacy, and security of information in its care seriously. Upon discovery, AGH immediately commenced an investigation to confirm the nature and scope of the incident. AGH reported this incident to law enforcement and are taking steps to implement additional safeguards and review policies and procedures relating to data privacy and security.

AGH encourages individuals to remain vigilant against incidents of identity theft and fraud, to review account statements and explanation of benefits forms, and monitoring free credit reports for suspicious activity, and detect errors.

Individuals who want additional information about this event can visit AGH's website at https://www.atlanticgeneral.org/.

SOURCE Atlantic General Hospital


These press releases may also interest you

at 15:06
REI Path Ahead Ventures is celebrating 16 emerging companies completing its Embark program, bringing the latest products and experiences to the outdoor industry. Embark is a three-month curriculum created in partnership with Founded Outdoors to...

at 15:00
BrainSell, the growth enablement company specializing in helping clients grow with top-of-the-line business technology solutions, has promoted Kevin Cook to Chief Technology Officer (CTO). Cook's 15 years at BrainSell, working across business...

at 14:54
Ferrilli, a leading provider of technology solutions for higher education institutions, proudly announces its recognition as the Ellucian Implementation Partner of the Year for 2023. This esteemed award marks the second consecutive year that Ferrilli...

at 14:46
A modified, upgraded, and perfectly preserved 2006 Pontiac GTO sponsored by CRC Industries will be auctioned May 15, 2024 with all proceeds going to TechForce Foundation, a nonprofit organization that funds education for and champions young people...

at 14:40
CareHive Health, a pioneer in data-driven, digital-first, white glove navigation solutions, proudly announces the appointment of Julianne Bride, MBA, as CareHive's Vice President of Strategic Partnerships and Client Success. Julianne Bride's...

at 14:37
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its enhanced bioassay platform EpiScreen® 2.0, a comprehensive suite of assays that predict and evaluate potential risks of...



News published on and distributed by: